Check-Cap responded to Nasdaq listing review comments to keep its merger with MBody AI on track. The deal targets a close by the first half of 2026. This administrative step clears a path for the company's transition into AI-driven healthcare. Investors now await final regulatory approval to finalize the $MBAI ticker listing.